Publication:
The use of rivaroxaban in deep venous thrombosis associated with vena cava inferior agenesis

Simple item page
dc.contributor.authorArikan, Ali Ahmet
dc.contributor.authorEmre, Selcuk
dc.contributor.authorAvni, Bayraktar Fatih
dc.contributor.institutionauthorSELÇUK, EMRE
dc.date.accessioned2020-05-22T20:59:13Z
dc.date.available2020-05-22T20:59:13Z
dc.date.issued2019-10-01T00:00:00Z
dc.description.abstractInferior vena cava agenesis is a rare anomaly which may result in deep vein thrombosis. There is no clear scientific evidence for the most effective therapeutic management, optimal duration, or the choice of anticoagulant therapy. Herein, we report an 18-year-old male case with deep vein thrombosis associated with inferior vena cava agenesis who was on rivaroxaban as a lifelong anticoagulation treatment for symptoms of venous stasis and the presence of heterozygotic thrombophilic mutations.
dc.identifier.citationArikan A. A. , Emre S., Avni B. F. , -The use of rivaroxaban in deep venous thrombosis associated with vena cava inferior agenesis-, TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, cilt.27, ss.583-585, 2019
dc.identifier.doi10.5606/tgkdc.dergisi.2019.17672
dc.identifier.pubmed
dc.identifier.scopus85074376735
dc.identifier.urihttps://hdl.handle.net/20.500.12645/18009
dc.identifier.wosWOS:000492824600028
dc.language.isoen
dc.titleThe use of rivaroxaban in deep venous thrombosis associated with vena cava inferior agenesis
dc.typeArticle
dspace.entity.typePublication
local.avesis.idd42dccac-011f-4983-85a4-ff6fae3bc33c
local.publication.isinternational1
relation.isAuthorOfPublicationa50f88d4-9546-4a07-82cb-e5f9abc849f7
relation.isAuthorOfPublication.latestForDiscoverya50f88d4-9546-4a07-82cb-e5f9abc849f7
Files
Collections
Silinecekler